Critical review of the safety assessment of titanium dioxide additives in food

Journal of Nanobiotechnology

Volumn 16, Issue 1, 2018, Pages

  Winkler, Hans Christian ^a   Notter, Tina ^b   Meyer, Urs ^b   Naegeli, Hanspeter ^b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Anatase; Cancer; Corona; Dendritic cells; Food additives; Food safety; Food toxicology; Innate immunity; Lymphoid tissue; Rutile

Indexed keywords

DIGITAL STORAGE; FOOD ADDITIVES; FOOD STORAGE; HEALTH RISKS; MAMMALS; NANOSTRUCTURED MATERIALS; OXIDE MINERALS; RISK ASSESSMENT; SAFETY ENGINEERING; TISSUE; TITANIUM DIOXIDE;

CANCER; CORONA; DENDRITIC CELLS; FOOD TOXICOLOGIES; INNATE IMMUNITY; LYMPHOID TISSUE; RUTILE;

FOOD SAFETY;

FOOD ADDITIVE; TITANIUM DIOXIDE; TITANIUM;

ACUTE TOXICITY; BIOAVAILABILITY; CARCINOGENICITY; CHEMICAL PARAMETERS; CHRONIC TOXICITY; DIETARY EXPOSURE; GASTROINTESTINAL TRACT; GENOTOXICITY; HUMAN; INTESTINE ABSORPTION; NONHUMAN; ORAL TOXICITY; PARTICLE CORONA; PARTICLE SIZE; PHYSICAL CHEMISTRY; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; TISSUE DISTRIBUTION; TOXICITY; TOXICOKINETICS; ANIMAL; CELL CULTURE; ENVIRONMENTAL EXPOSURE; MOUSE; TOXICITY TESTING;

ANIMALS; CELLS, CULTURED; ENVIRONMENTAL EXPOSURE; FOOD ADDITIVES; HUMANS; MICE; TITANIUM; TOXICITY TESTS;

EID: 85048021309     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-018-0376-8     Document Type: Review

References (147)

1. Kassebaum NJ, G. B. D. Anemia Collaborators: the global burden of anemia. Hematol Oncol Clin N Am. 2013;2016(30):247-308. https://doi.org/10.1016/j.hoc.2015.11.002.
2. Shen Y, Posavec L, Bolisetty S, Hilty FM, Nystrom G, Kohlbrecher J, Hilbe M, Rossi A, Baumgartner J, Zimmermann MB, Mezzenga R. Amyloid fibril systems reduce, stabilize and deliver bioavailable nanosized iron. Nat Nanotechnol. 2017;12:642-7. https://doi.org/10.1038/nnano.2017.58.
3. von Moos LM, Schneider M, Hilty FM, Hilbe M, Arnold M, Ziegler N, Mato DS, Winkler H, Tarik M, Ludwig C, et al. Iron phosphate nanoparticles for food fortification: biological effects in rats and human cell lines. Nanotoxicology. 2017;11:496-506. https://doi.org/10.1080/17435390.2017.1314035.
4. Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, Aitken R, Watkins R. Applications and implications of nanotechnologies for the food sector. Food Addit Contam. 2008;25:241-58. https://doi.org/10.1080/02652030701744538.
5. Puddu M, Paunescu D, Stark WJ, Grass RN. Magnetically recoverable, thermostable, hydrophobic DNA/silica encapsulates and their application as invisible oil tags. ACS Nano. 2014;8:2677-85. https://doi.org/10.1021/nn4063853.
6. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol. 2012;46:2242-50. https://doi.org/10.1021/es204168d.
7. Peters RJB, van Bemmel G, Herrera-Rivera Z, Helsper HPFG, Marvin HJP, Weigel S, Tromp PC, Oomen AG, Rietveld AG, Bouwmeester H. Characterization of titanium dioxide nanoparticles in food products: analytical methods to define nanoparticles. J Agric Food Chem. 2014;62:6285-93. https://doi.org/10.1021/jf5011885.
8. Yang Y, Doudrick K, Bi XY, Hristovski K, Herckes P, Westerhoff P, Kaegi R. Characterization of food-grade titanium dioxide: the presence of nanosized particles. Environ Sci Technol. 2014;48:6391-400. https://doi.org/10.1021/es500436x.
9. Codex Alimentarius, International food standards. http://www.codexalimentarius.org/. Accessed 28 Nov 2017.
10. 2. GIT Lab J Europe. 2010;14:42-3.
11. Code of Federal Regulations. Listing of color additives exempt from certification https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=73.575. Accessed 30 Nov 2017.
12. Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. http://eur-lex.europa.eu/eli/reg/2008/1333/2014-04-14. Accessed 01 Dec 2017.
13. EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food). Re-evaluation of titanium dioxide (E 171) as a food additive. EFSA J. 2016;14(9):4545. https://doi.org/10.2903/j.efsa.2016.4545.
14. Oberdörster G. Toxicology of ultrafine particles: in vivo studies. Philos Transact R Soc Lond Ser A Math Phys a Eng Sci. 2000;358:2719-39. https://doi.org/10.1098/rsta.2000.0680.
15. Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. Ultrafine particles. Occup Environ Med. 2001;58(211-216):199.
16. Brun E, Barreau F, Veronesi G, Fayard B, Sorieul S, Chaneac C, Carapito C, Rabilloud T, Mabondzo A, Herlin-Boime N, Carriere M. Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia. Part Fibre Toxicol. 2014;11:13. https://doi.org/10.1186/1743-8977-11-13.
17. 2 nanoparticles by Caco-2 intestinal cells. Toxicol Lett. 2014;226:264-76. https://doi.org/10.1016/j.toxlet.2014.02.014.
18. Urrutia-Ortega IM, Garduno-Balderas LG, Delgado-Buenrostro NL, Freyre-Fonseca V, Flores-Flores JO, Gonzalez-Robles A, Pedraza-Chaverri J, Hernandez-Pando R, Rodriguez-Sosa M, Leon-Cabrera S, et al. Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model. Food Chem Toxicol. 2016;93:20-31. https://doi.org/10.1016/j.fct.2016.04.014.
19. Commission EU. Commission recommendation of 18 October 2011 on the definition of nanomaterial (2011/696/EU). Off J Eur Commun Legis. 2011;275:38-9.
20. Methods for the implementation of the European definition of a nanomaterial. http://www.nanodefine.eu/index.php/nanodefine-publications/nanodefine-technical-reports. Accessed 05 Dec 2017.
21. Oberdörster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect. 1994;102(Suppl 5):173-9.
22. 2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol Sci. 2006;91:227-36. https://doi.org/10.1093/toxsci/kfj140.
23. Sager TM, Kommineni C, Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol. 2008;5:17. https://doi.org/10.1186/1743-8977-5-17.
24. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Cogliano V, W. H. O. International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol. 2006;7:295-6.
25. 2) by inhalation for two years. Toxicol Appl Pharmacol. 1985;79:179-92.
26. IARC Working Group on the Evaluation of Carcinogenic. Risks to humans: carbon black, titanium dioxide, and talc. IARC Monogr Eval Carcinog Risks Hum. 2010;93:1.
27. Pietroiusti A, Bergamaschi E, Campagna M, Campagnolo L, De Palma G, Iavicoli S, Leso V, Magrini A, Miragoli M, Pedata P, et al. The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group. Part Fibre Toxicol. 2017;14:47. https://doi.org/10.1186/s12989-017-0226-0.
28. Shi H, Magaye R, Castranova V, Zhao J. Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol. 2013;10:15. https://doi.org/10.1186/1743-8977-10-15.
29. Heringa MB, Geraets L, van Eijkeren JC, Vandebriel RJ, de Jong WH, Oomen AG. Risk assessment of titanium dioxide nanoparticles via oral exposure, including toxicokinetic considerations. Nanotoxicology. 2016;10:1515-25. https://doi.org/10.1080/17435390.2016.1238113.
30. Diebold U. The surface science of titanium dioxide. Surf Sci Rep. 2003;48:53-229.
31. Theissmann R, Kluwig M, Koch T. A reproducible number-based sizing method for pigment-grade titanium dioxide. Beilstein J Nanotechnol. 2014;5:1815-22. https://doi.org/10.3762/bjnano.5.192.
32. Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council (Text with EEA relevance) https://publications.europa.eu/s/etMb. Accessed 05 Dec 2017.
33. Matthews A. The crystallization of anatase and rutile from amorphous titanium dioxide under hydrothermal conditions. Am Mineral. 1976;61:419-24.
34. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci. 2006;92:174-85. https://doi.org/10.1093/toxsci/kfj197.
35. Vandebriel RJ, Vermeulen JP, van Engelen LB, de Jong B, Verhagen LM, de la Fonteyne-Blankestijn LJ, Hoonakker ME, de Jong WH. The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo. Part Fibre Toxicol. 2018;15:9. https://doi.org/10.1186/s12989-018-0245-5.
36. Rompelberg C, Heringa MB, van Donkersgoed G, Drijvers J, Roos A, Westenbrink S, Peters R, van Bemmel G, Brand W, Oomen AG. Oral intake of added titanium dioxide and its nanofraction from food products, food supplements and toothpaste by the Dutch population. Nanotoxicology. 2016;10:1404-14. https://doi.org/10.1080/17435390.2016.1222457.
37. Farrell TP, Magnuson B. Absorption, distribution and excretion of four forms of titanium dioxide pigment in the rat. J Food Sci. 2017;82:1985-93. https://doi.org/10.1111/1750-3841.13791.
38. JECFA. Compendium of food additive specifications. Geneva: World Health Organization; 2012.
39. Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol. 2013;10:9. https://doi.org/10.1186/1743-8977-10-9.
40. MacNicoll A, Kelly M, Aksoy H, Kramer E, Bouwmeester H, Chaudhry Q. A study of the uptake and biodistribution of nano-titanium dioxide using in vitro and in vivo models of oral intake. J Nanopart Res. 2015;17:66. https://doi.org/10.1007/s11051-015-2862-3.
41. Mie G. Contribution to the optical properties of turbid media, in particular of colloidal suspensions of metals. Ann Phys. 1908;25:377-445.
42. Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, Jia G, Gao Y, Li B, Sun J, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett. 2007;168:176-85. https://doi.org/10.1016/j.toxlet.2006.12.001.
43. Chaudhry Q, SCCS. Opinion of the Scientific Committee on Consumer safety (SCCS)-revision of the opinion on the safety of the use of titanium dioxide, nano form, in cosmetic products. Regul Toxicol Pharmacol. 2015;73:669-70. https://doi.org/10.1016/j.yrtph.2015.09.005.
44. SCCS (Scientific Committee on Consumer Safety). Opinion on titanium dioxide (nano form), 22 July 2013, revision of 22 April 2014. https://doi.org/10.2772/70108. 2014.
45. Dudefoi W, Terrisse H, Richard-Plouet M, Gautron E, Popa F, Humbert B, Ropers MH. Criteria to define a more relevant reference sample of titanium dioxide in the context of food: a multiscale approach. Food Addit Contam Part A. 2017;34:653-65. https://doi.org/10.1080/19440049.2017.1284346.
46. 2 nanoparticles in the coatings of chewing gums. Food Addit Contam Part A. 2017. https://doi.org/10.1080/19440049.2017.1384576.
47. 2) nanoparticles. Nanotoxicology. 2015;9:373-80. https://doi.org/10.3109/17435390.2014.940404.
48. Sprong C, Bakker M, Niekerk M, Vennemann M. Exposure assessment of the food additive titanium dioxide (E 171) based on use levels provided by the industry. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2016.
49. Helander HF, Fandriks L. Surface area of the digestive tract-revisited. Scand J Gastroenterol. 2014;49:681-9. https://doi.org/10.3109/00365521.2014.898326.
50. Cornes JS. Number, size, and distribution of Peyer's patches in the human small intestine: Part I. The development of Peyer's patches. Gut. 1965;6:225-9.
51. Powell JJ, Ainley CC, Harvey RS, Mason IM, Kendall MD, Sankey EA, Dhillon AP, Thompson RP. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut. 1996;38:390-5.
52. Da Silva C, Wagner C, Bonnardel J, Gorvel JP, Lelouard H. The Peyer's patch mononuclear phagocyte system at steady state and during infection. Front Immunol. 2017;8:1254. https://doi.org/10.3389/fimmu.2017.01254.
53. Hussain N, Jaitley V, Florence AT. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev. 2001;50:107-42.
54. Rescigno M. Before they were gut dendritic cells. Immunity. 2009;31:454-6. https://doi.org/10.1016/j.immuni.2009.08.015.
55. Powell JJ, Faria N, Thomas-McKay E, Pele LC. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun. 2010;34:J226-33. https://doi.org/10.1016/j.jaut.2009.11.006.
56. Hummel TZ, Kindermann A, Stokkers PCF, Benninga MA, ten Kate FJW. Exogenous pigment in Peyer patches of children suspected of having IBD. J Pediatr Gastroenterol Nutr. 2014;58:477-80. https://doi.org/10.1097/Mpg.0000000000000221.
57. Powell JJ, Thomas-McKay E, Thoree V, Robertson J, Hewitt RE, Skepper JN, Brown A, Hernandez-Garrido JC, Midgley PA, Gomez-Morilla I, et al. An endogenous nanomineral chaperones luminal antigen and peptidoglycan to intestinal immune cells. Nat Nanotechnol. 2015;10:361-9. https://doi.org/10.1038/nnano.2015.19.
58. Liu R, Zhang X, Pu Y, Yin L, Li Y, Zhang X, Liang G, Li X, Zhang J. Small-sized titanium dioxide nanoparticles mediate immune toxicity in rat pulmonary alveolar macrophages in vivo. J Nanosci Nanotechnol. 2010;10:5161-9.
59. Muhlfeld C, Geiser M, Kapp N, Gehr P, Rothen-Rutishauser B. Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the "relative deposition index": evidence for clearance through microvasculature. Part Fibre Toxicol. 2007;4:7. https://doi.org/10.1186/1743-8977-4-7.
60. 2) nanoparticles into intact and damaged skin in vitro. J Toxicol Sci. 2010;35:107-13.
61. 2 particles. Toxicol Sci. 2010;115:156-66. https://doi.org/10.1093/toxsci/kfq041.
62. Newman MD, Stotland M, Ellis JI. The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. J Am Acad Dermatol. 2009;61:685-92. https://doi.org/10.1016/j.jaad.2009.02.051.
63. Gamer AO, Leibold E, van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro. 2006;20:301-7. https://doi.org/10.1016/j.tiv.2005.08.008.
64. Kreyling WG, Holzwarth U, Schleh C, Kozempel J, Wenk A, Haberl N, Hirn S, Schaffler M, Lipka J, Semmler-Behnke M, Gibson N. Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: part 2. Nanotoxicology. 2017;11:443-53. https://doi.org/10.1080/17435390.2017.1306893.
65. Gu N, Hu H, Guo Q, Jin S, Wang C, Oh Y, Feng Y, Wu Q. Effects of oral administration of titanium dioxide fine-sized particles on plasma glucose in mice. Food Chem Toxicol. 2015;86:124-31. https://doi.org/10.1016/j.fct.2015.10.003.
66. Jani PU, Mccarthy DE, Florence AT. Titanium-dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral-administration. Int J Pharm. 1994;105:157-68. https://doi.org/10.1016/0378-5173(94)90461-8.
67. Geraets L, Oomen AG, Krystek P, Jacobsen NR, Wallin H, Laurentie M, Verharen HW, Brandon EF, de Jong WH. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol. 2014;11:30. https://doi.org/10.1186/1743-8977-11-30.
68. Tassinari R, Cubadda F, Moracci G, Aureli F, D'Amato M, Valeri M, De Berardis B, Raggi A, Mantovani A, Passeri D, et al. Oral, short-term exposure to titanium dioxide nanoparticles in Sprague-Dawley rat: focus on reproductive and endocrine systems and spleen. Nanotoxicology. 2014;8:654-62. https://doi.org/10.3109/17435390.2013.822114.
69. Florence AT. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res. 1997;14:259-66.
70. Böckmann J, Lahl H, Eckhert T, Unterhalt B. Blood levels of titanium before and after oral administration of titanium dioxide. Pharmazie. 2000;55:140-3.
71. Jones K, Morton J, Smith I, Jurkschat K, Harding AH, Evans G. Human in vivo and in vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles. Toxicol Lett. 2015;233:95-101. https://doi.org/10.1016/j.toxlet.2014.12.005.
72. Pele LC, Thoree V, Bruggraber SFA, Koller D, Thompson RPH, Lomer MC, Powell JJ. Pharmaceutical/food grade titanium dioxide particles are absorbed into the bloodstream of human volunteers. Part Fibre Toxicol. 2015;12:26. https://doi.org/10.1186/s12989-015-0101-9.
73. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8:543-57. https://doi.org/10.1038/Nmat2442.
74. Ruh H, Kuhl B, Brenner-Weiss G, Hopf C, Diabate S, Weiss C. Identification of serum proteins bound to industrial nanomaterials. Toxicol Lett. 2012;208:41-50. https://doi.org/10.1016/j.toxlet.2011.09.009.
75. Walkey CD, Chan WCW. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41:2780-99. https://doi.org/10.1039/c1cs15233e.
76. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA. 2007;104:2050-5. https://doi.org/10.1073/pnas.0608582104.
77. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA. 2008;105:14265-70. https://doi.org/10.1073/pnas.0805135105.
78. McCracken C, Zane A, Knight DA, Dutta PK, Waldman WJ. Minimal intestinal epithelial cell toxicity in response to short- and long-term food-relevant inorganic nanoparticle exposure. Chem Res Toxicol. 2013;26:1514-25. https://doi.org/10.1021/tx400231u.
79. DeLoid GM, Wang Y, Kapronezai K, Lorente LR, Zhang R, Pyrgiotakis G, Konduru NV, Ericsson M, White JC, De La Torre-Roche R, et al. An integrated methodology for assessing the impact of food matrix and gastrointestinal effects on the biokinetics and cellular toxicity of ingested engineered nanomaterials. Part Fibre Toxicol. 2017;14:40. https://doi.org/10.1186/s12989-017-0221-5.
80. McClements DJ, DeLoid G, Pyrgiotakis G, Shatkin JA, Xiao H, Demokritou P. The role of the food matrix and gastrointestinal tract in the assessment of biological properties of ingested engineered nanomaterials (iENMs): State of the science and knowledge gaps. NanoImpact. 2016;3-4:47-57. https://doi.org/10.1016/j.impact.2016.10.002.
81. Nagayama S, Ogawara K, Fukuoka Y, Higaki K, Kimura T. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm. 2007;342:215-21. https://doi.org/10.1016/j.ijpharm.2007.04.036.
82. Warheit DB, Brown SC, Donner EM. Acute and subchronic oral toxicity studies in rats with nanoscale and pigment grade titanium dioxide particles. Food Chem Toxicol. 2015;84:208-24. https://doi.org/10.1016/j.fct.2015.08.026.
83. 2 nanoparticles induce oxidative DNA damage and apoptosis in human liver cells. Nanotoxicology. 2013;7:48-60. https://doi.org/10.3109/17435390.2011.629747.
84. Azim SA, Darwish HA, Rizk MZ, Ali SA, Kadry MO. Amelioration of titanium dioxide nanoparticles-induced liver injury in mice: possible role of some antioxidants. Exp Toxicol Pathol. 2015;67:305-14. https://doi.org/10.1016/j.etp.2015.02.001.
85. Orazizadeh M, Fakhredini F, Mansouri E, Khorsandi L. Effect of glycyrrhizic acid on titanium dioxide nanoparticles-induced hepatotoxicity in rats. Chem Biol Interact. 2014;220:214-21. https://doi.org/10.1016/j.cbi.2014.07.001.
86. 2 exposure on testosterone synthesis and spermatogenesis in mice. Arch Toxicol. 2014;88:781-8. https://doi.org/10.1007/s00204-013-1167-5.
87. Chen ZJ, Wang Y, Ba T, Li Y, Pu J, Chen T, Song YS, Gu YG, Qian Q, Yang JL, Jia G. Genotoxic evaluation of titanium dioxide nanoparticles in vivo and in vitro. Toxicol Lett. 2014;226:314-9. https://doi.org/10.1016/j.toxlet.2014.02.020.
88. Wang Y, Chen Z, Ba T, Pu J, Chen T, Song Y, Gu Y, Qian Q, Xu Y, Xiang K, et al. Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles. Small. 2013;9:1742-52. https://doi.org/10.1002/smll.201201185.
89. Dunkel VC, Zeiger E, Brusick D, McCoy E, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VF. Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli. Environ Mutagen. 1985;7(Suppl 5):1-248.
90. Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, et al. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 1987;236:933-41.
91. Nakagawa Y, Wakuri S, Sakamoto K, Tanaka N. The photogenotoxicity of titanium dioxide particles. Mutat Res. 1997;394:125-32.
92. 2 particles as a component of nanoparticle risk management. Toxicol Lett. 2007;171:99-110. https://doi.org/10.1016/j.toxlet.2007.04.008.
93. Landsiedel R, Ma-Hock L, Van Ravenzwaay B, Schulz M, Wiench K, Champ S, Schulte S, Wohlleben W, Oesch F. Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations. Nanotoxicology. 2010;4:364-81. https://doi.org/10.3109/17435390.2010.506694.
94. Rahman Q, Lohani M, Dopp E, Pemsel H, Jonas L, Weiss DG, Schiffmann D. Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ Health Perspect. 2002;110:797-800. https://doi.org/10.1289/ehp.02110797.
95. Bhattacharya K, Davoren M, Boertz J, Schins RP, Hoffmann E, Dopp E. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part Fibre Toxicol. 2009;6:17. https://doi.org/10.1186/1743-8977-6-17.
96. 2. Hum Exp Toxicol. 2009;28:339-52. https://doi.org/10.1177/0960327109105163.
97. Karlsson HL, Gustafsson J, Cronholm P, Moller L. Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size. Toxicol Lett. 2009;188:112-8. https://doi.org/10.1016/j.toxlet.2009.03.014.
98. Hackenberg S, Friehs G, Kessler M, Froelich K, Ginzkey C, Koehler C, Scherzed A, Burghartz M, Kleinsasser N. Nanosized titanium dioxide particles do not induce DNA damage in human peripheral blood lymphocytes. Environ Mol Mutagen. 2011;52:264-8. https://doi.org/10.1002/em.20615.
99. Wang SG, Hunter LA, Arslan Z, Wilkerson MG, Wickliffe JK. Chronic exposure to nanosized, anatase titanium dioxide is not cyto- or genotoxic to Chinese hamster ovary cells. Environ Mol Mutagen. 2011;52:614-22. https://doi.org/10.1002/em.20660.
100. Guichard Y, Schmit J, Darne C, Gate L, Goutet M, Rousset D, Rastoix O, Wrobel R, Witschger O, Martin A, et al. Cytotoxicity and genotoxicity of nanosized and microsized titanium dioxide and iron oxide particles in Syrian hamster embryo cells. Ann Occup Hyg. 2012;56:631-44. https://doi.org/10.1093/annhyg/mes006.
101. Jugan ML, Barillet S, Simon-Deckers A, Herlin-Boime N, Sauvaigo S, Douki T, Carriere M. Titanium dioxide nanoparticles exhibit genotoxicity and impair DNA repair activity in A549 cells. Nanotoxicology. 2012;6:501-13. https://doi.org/10.3109/17435390.2011.587903.
102. Magdolenova Z, Bilanicova D, Pojana G, Fjellsbo LM, Hudecova A, Hasplova K, Marcomini A, Dusinska M. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit. 2012;14:455-64.
103. Toyooka T, Amano T, Ibuki Y. Titanium dioxide particles phosphorylate histone H2AX independent of ROS production. Mutat Res Genet Toxicol Environ Mutagen. 2012;742:84-91. https://doi.org/10.1016/j.mrgentox.2011.12.015.
104. 3 nanoparticles on genotoxic responses in human peripheral blood lymphocytes and cultured embyronic kidney cells. J Toxicol Environ Health A. 2013;76:990-1002. https://doi.org/10.1080/15287394.2013.830584.
105. Prasad RY, Wallace K, Daniel KM, Tennant AH, Zucker RM, Strickland J, Dreher K, Kligerman AD, Blackman CF, Demarini DM. Effect of treatment media on the agglomeration of titanium dioxide nanoparticles: impact on genotoxicity, cellular interaction, and cell cycle. ACS Nano. 2013;7:1929-42. https://doi.org/10.1021/nn302280n.
106. Tavares AM, Louro H, Antunes S, Quarre S, Simar S, De Temmerman PJ, Verleysen E, Mast J, Jensen KA, Norppa H, et al. Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes. Toxicol In Vitro. 2014;28:60-9. https://doi.org/10.1016/j.tiv.2013.06.009.
107. Vales G, Rubio L, Marcos R. Long-term exposures to low doses of titanium dioxide nanoparticles induce cell transformation, but not genotoxic damage in BEAS-2B cells. Nanotoxicology. 2015;9:568-78. https://doi.org/10.3109/17435390.2014.957252.
108. 2 anatase nanoparticles in B6C3F1 male mice evaluated using Pig-a and flow cytometric micronucleus assays. Mutat Res Genet Toxicol Environ Mutagen. 2012;745:65-72. https://doi.org/10.1016/j.mrgentox.2012.02.002.
109. Louro H, Tavares A, Vital N, Costa PM, Alverca E, Zwart E, Jong WH, Fessard V, Lavinha J, Silva MJ. Integrated approach to the in vivo genotoxic effects of a titanium dioxide nanomaterial using LacZ plasmid-based transgenic mice. Environ Mol Mutagen. 2014;55:500-9.
110. Dobrzynska MM, Gajowik A, Radzikowska J, Lankoff A, Dusinska M, Kruszewski M. Genotoxicity of silver and titanium dioxide nanoparticles in bone marrow cells of rats in vivo. Toxicology. 2014;315:86-91. https://doi.org/10.1016/j.tox.2013.11.012.
111. 2-induced clastogenicity, genotoxicity and mutagenicity by chlorophyllin administration in mice brain, liver, and bone marrow cells. Toxicol Sci. 2014;142:21-32. https://doi.org/10.1093/toxsci/kfu157.
112. National Toxicology Program. Bioassay of titanium dioxide for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser. 1979;97:1-123.
113. Alison RH, Capen CC, Prentice DE. Neoplastic lesions of questionable significance to humans. Toxicol Pathol. 1994;22:179-86. https://doi.org/10.1177/019262339402200211.
114. Warheit DB, Boatman R, Brown SC. Developmental toxicity studies with 6 forms of titanium dioxide test materials (3 pigment-different grade & 3 nanoscale) demonstrate an absence of effects in orally-exposed rats. Regul Toxicol Pharmacol. 2015;73:887-96. https://doi.org/10.1016/j.yrtph.2015.09.032.
115. 2 2015: Tested by KIT; 2007.
116. Mohammadipour A, Fazel A, Haghir H, Motejaded F, Rafatpanah H, Zabihi H, Hosseini M, Bideskan AE. Maternal exposure to titanium dioxide nanoparticles during pregnancy; impaired memory and decreased hippocampal cell proliferation in rat offspring. Environ Toxicol Pharmacol. 2014;37:617-25. https://doi.org/10.1016/j.etap.2014.01.014.
117. Waller T, Chen C, Walker SL. Food and industrial grade titanium dioxide impacts gut microbiota. Environ Eng Sci. 2017;34:537-50. https://doi.org/10.1089/ees.2016.0364.
118. 2 particles on a human intestinal community. Food Chem Toxicol. 2017;106:242-9. https://doi.org/10.1016/j.fct.2017.05.050.
119. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995;182:389-400.
120. Steinman RM, Lustig DS, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J Exp Med. 1974;139:1431-45.
121. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-52. https://doi.org/10.1038/32588.
122. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol. 2008;38:1404-13. https://doi.org/10.1002/eji.200737984.
123. 2 nanoparticles in murine dendritic cells. Nanotoxicology. 2011;5:326-40. https://doi.org/10.3109/17435390.2010.506957.
124. Ruiz PA, Moron B, Becker HM, Lang S, Atrott K, Spalinger MR, Scharl M, Wojtal KA, Fischbeck-Terhalle A, Frey-Wagner I, et al. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut. 2017;66:1216-24. https://doi.org/10.1136/gutjnl-2015-310297.
125. Limbach LK, Li YC, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol. 2005;39:9370-6. https://doi.org/10.1021/es051043o.
126. Evans SM, Ashwood P, Warley A, Berisha F, Thompson RP, Powell JJ. The role of dietary microparticles and calcium in apoptosis and interleukin-1β release of intestinal macrophages. Gastroenterology. 2002;123:1543-53.
127. Butler M, Boyle JJ, Powell JJ, Playford RJ, Ghosh S. Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res. 2007;56:353-61. https://doi.org/10.1007/s00011-007-7068-4.
128. Ashwood P, Thompson RPH, Powell JJ. Fine particles that adsorb lipopolysaccharide via bridging calcium cations may mimic bacterial pathogenicity towards cells. Exp Biol Med. 2007;232:107-17.
129. Riedle S, Pele LC, Otter DE, Hewitt RE, Singh H, Roy NC, Powell JJ. Pro-inflammatory adjuvant properties of pigment-grade titanium dioxide particles are augmented by a genotype that potentiates interleukin 1β processing. Part Fibre Toxicol. 2017;14:51.
130. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-6. https://doi.org/10.1038/35079114.
131. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. https://doi.org/10.1038/35079107.
132. Mahler GJ, Esch MB, Tako E, Southard TL, Archer SD, Glahn RP, Shuler ML. Oral exposure to polystyrene nanoparticles affects iron absorption. Nat Nanotechnol. 2012;7:264-71. https://doi.org/10.1038/nnano.2012.3.
133. Guo Z, Martucci NJ, Moreno-Olivas F, Tako E, Mahler GJ. Titanium dioxide nanoparticle ingestion alters nutrient absorption in an in vitro model of the small intestine. NanoImpact. 2017;5:70-82. https://doi.org/10.1016/j.impact.2017.01.002.
134. 2 nanoparticle-induced genotoxicity persistence and possible chronic gastritis-induction in mice. Food Chem Toxicol. 2015;83:76-83. https://doi.org/10.1016/j.fct.2015.05.018.
135. 2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. Sci Rep. 2017;7:40373. https://doi.org/10.1038/srep40373.
136. JECFA (Joint FAO/WHO Expert Committee on Food Additives). Thirteenth report of the Joint FAO/WHO Expert Committee on food additives. Specifications for the identity and purity of food additives and their toxicological evaluation. In WHO Tech Rep Ser, vol. 445. Geneva: WHO. 1970.
137. EFSA Scientific Comittee. Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. EFSA J. 2012;10:2579. https://doi.org/10.2903/j.efsa.2012.2579.
138. Lomer MC, Thompson RP, Powell JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc. 2002;61:123-30.
139. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620-5. https://doi.org/10.1038/nature07008.
140. Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol. 2009;15:2081-8.
141. Bates J, Diehl L. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol. 2014;232:112-20. https://doi.org/10.1002/path.4277.
142. Tetley TD. Health effects of nanomaterials. Biochem Soc Trans. 2007;35:527-31. https://doi.org/10.1042/BST0350527.
143. Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, Dobrovolskaia MA. Minireview: nanoparticles and the immune system. Endocrinology. 2010;151:458-65. https://doi.org/10.1210/en.2009-1082.
144. OECD. Test No. 408: repeated dose 90-day oral toxicity study in rodents. 1998. https://doi.org/10.1787/9789264070707-en.
145. OECD. Test No. 407: repeated dose 28-day oral toxicity study in rodents. 2008. https://doi.org/10.1787/9789264070684-en.
146. Winkler HC, Kornprobst J, Wick P, von Moos LM, Trantakis I, Schraner EM, Bathke B, Hochrein H, Suter M, Naegeli H. MyD88-dependent pro-interleukin-1beta induction in dendritic cells exposed to food-grade synthetic amorphous silica. Part Fibre Toxicol. 2017;14:21. https://doi.org/10.1186/s12989-017-0202-8.
147. Gogos A, Moll J, Klingenfuss F, van der Heijden M, Irin F, Green MJ, Zenobi R, Bucheli TD. Vertical transport and plant uptake of nanoparticles in a soil mesocosm experiment. J Nanobiotechnol. 2016;14:40. https://doi.org/10.1186/s12951-016-0191-z.